Cargando…
Evaluation of Increased Adherence and Cost Savings of an Employer Value-Based Benefits Program Targeting Generic Antihyperlipidemic and Antidiabetic Medications
BACKGROUND: A major employer implemented a change to its employee health benefits program to allow beneficiaries with diabetes or high cholesterol to obtain preselected generic antidiabetic or generic antihyperlipidemic medications with a zero dollar copayment. To receive this benefit, plan benefici...
Autores principales: | Clark, Bobby, DuChane, Janeen, Hou, John, Rubinstein, Elan, McMurray, Jennifer, Duncan, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438126/ https://www.ncbi.nlm.nih.gov/pubmed/24456315 http://dx.doi.org/10.18553/jmcp.2014.20.2.141 |
Ejemplares similares
-
New all oral therapy for chronic hepatitis C virus (HCV): a novel long-term cost comparison
por: Poonsapaya, Jennifer M., et al.
Publicado: (2015) -
Antihyperlipidemic and antidiabetic effects of umbelliferone in streptozotocin diabetic rats.
por: Ramesh, B., et al.
Publicado: (2005) -
Evaluation of Antidiabetic and Antihyperlipidemic Effects of Peganum harmala Seeds in Diabetic Rats
por: Komeili, Gholamreza, et al.
Publicado: (2016) -
Antidiabetic and antihyperlipidemic effect of Duvalia corderoyi in rats with streptozotocin-induced diabetes
por: AlFaris, Nora A., et al.
Publicado: (2020) -
Antidiabetic and antihyperlipidemic effects of Premna spinosa bark in experimental animal models
por: Rout, Rama Chandra, et al.
Publicado: (2022)